Navigation Links
Switzerland Posts Biotech Gains in 2009
Date:5/26/2010

NEW YORK, May 26 /PRNewswire/ -- Despite a less than favorable global economic environment the Swiss biotechnology industry performed rather well in 2009, reports Mario Brossi, North American senior advisor for Switzerland Trade and Investment Promotion.  According to the Swiss Biotech Report 2010 employment in the sector grew 6% to 19,071 while turnover reached CHF 9.3 billion*, a 7% increase over the prior year.

"The report notes that while the financing environment was challenging, Swiss companies were able to raise CHF 370 million in new capital, led by NovImmune's CHF 60 million in venture capital," Mr. Brossi said.  "BioMedInvest II raised CHF 100 million in new capital and Index Ventures EUR 350 million for early stage investment."

In other activity mondoBiotech floated its shares on the SWX Swiss Exchange, Evolva became public through a reverse merger with Arpida, and ESBATech in a transaction worth up to CHF 600 million was acquired by eye care leader Alcon.

"A measure of a country's ranking in a particular field is the number of patents filed per million of population," Mr. Brossi said.  "The World Patent Index reports that for Switzerland the number of biotech patents registered under this criterion is about 250.  This compares favorably with the U.S. (70), Japan (65), Germany (45), and Great Britain (40).  Much of the country's success in biotech is due to strong Federal support, its network of excellent research institu
'/>"/>

SOURCE Switzerland Trade and Investment Promotion
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland
2. Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg
3. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
4. 16th International Process Development Conference to be Held June 14-17, 2009 in Arosa, Switzerland
5. Diffusion Pharmaceuticals Announces Completion of a $2.9 Million Private Placement and Company Presentations at Upcoming Industry Conferences in Geneva, Switzerland and Naples, Florida
6. Pharmaxis Aridol Approved for Sale in Switzerland
7. 220 Companies Place Switzerland First in Biotech Density Per Capita
8. First CyberKnife System Sold in Switzerland
9. Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland
10. Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007
11. OpenQ Posts a 200% Revenue Growth in the First Half of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... VA (PRWEB) , ... August 27, 2015 , ... ... contractors solve complex business problems, is pleased to announce their ranking as one of ... annual ranking of the fastest-growing private companies across the nation. , “It is truly ...
(Date:8/27/2015)... 27, 2015 The National Necrotizing Fasciitis ... life—were saved by doctors at Vanderbilt University Hospital in ... NovaBay Pharmaceuticals and Dr. John Crew , director ... Seton Medical Center in Daly City, CA. ... breakthrough approach, pioneered by Dr. Crew, that had previously ...
(Date:8/27/2015)... SAN DIEGO , Aug. 27, 2015 ... second annual meeting of the Japan Society of HTLV-1, ... Science Institute Auditorium. The purpose of the Society is ... well as the development of medical technology and research ... health and welfare. "HUYA is proud to ...
(Date:8/27/2015)... ... August 27, 2015 , ... METTLER TOLEDO's web-based ... the product choices to a manageable shortlist of bench and floor scales and ... that fit best with the customer’s industry and application. , Side-by-side product ...
Breaking Biology Technology:Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4METTLER TOLEDO Updates Online Scale Selection Tool 2
... ARIUS Research Inc., (TSX:,ARI), a biotechnology company discovering ... announced its financial and operational,results for the first ... "During the quarter, we continued to focus ... human clinical trials. Most,significantly, we completed our pre-IND ...
... In the event of an outbreak or a bioterrorist ... virulence or drug resistance is essential to mounting an ... a pathogen genome is time-intensive and likely impractical during ... comparative genomics strategy to drastically reduce the time needed ...
... for Use as Pharmacologic ... in Myocardial Perfusion Imaging-, PALO ALTO, Calif. and ... CVTX ) and Astellas Pharma US, Inc. today,announced ... approved,Lexiscan(TM) (regadenoson) injection, an A2A adenosine receptor agonist,for use ...
Cached Biology Technology:ARIUS announces first quarter fiscal 2008 financial results 2ARIUS announces first quarter fiscal 2008 financial results 3ARIUS announces first quarter fiscal 2008 financial results 4ARIUS announces first quarter fiscal 2008 financial results 5ARIUS announces first quarter fiscal 2008 financial results 6ARIUS announces first quarter fiscal 2008 financial results 7ARIUS announces first quarter fiscal 2008 financial results 8ARIUS announces first quarter fiscal 2008 financial results 9ARIUS announces first quarter fiscal 2008 financial results 10ARIUS announces first quarter fiscal 2008 financial results 11ARIUS announces first quarter fiscal 2008 financial results 12Scientists develop strategy to rapidly describe outbreak strains with next-generation DNA sequencing 2CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 2CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 3CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 4CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 5
(Date:8/17/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... The new marketing campaign is being spearheaded by an ... ( http://amplitudemarketing.com/ ) and TPMG ( http://tmpg.com/ ). ... driven marketing and brand awareness and has a client ...
(Date:8/12/2015)... 12, 2015  New research unveiled at Black ... phones to steal users, fingerprints. Information released today ... fingerprint scanners on mobile devices, making the security ... biometrics on mobile devices, HYPR Corp. recently released ... authentication systems with strong cryptographic security. More information ...
(Date:8/10/2015)... and TELTOW, Germany , ... Instruments (SMI), a world leader in Eye Tracking ... completion of its OEM Eye Tracking Platform for integration ... Tracking Platform contains reference designs for seamless integration of ... systems, virtual reality HMDs and augmented reality smart glasses. ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
... event of an infection, the immune system releases messenger ... defeat invading pathogens, or inhibit them to prevent an ... to decide very quickly what mixture of activating and ... from the Helmholtz-Centre for Infection Research in Braunschweig, Germany, ...
... the Genome Institute of Singapore (GIS), a biomedical research ... (A*STAR), and their colleagues from the National University of ... Princeton University have recently discovered that viruses that ,invaded, ... the way genes get turned on and off in ...
... brain by the hunger-signaling hormone ghrelin, researchers say. The ... pharmacologic control of cholesterol levels. The animal ... University of Cincinnati (UC) endocrinology division, appears online ahead ... Neuroscience . "We have long thought that ...
Cached Biology News:The right response to every pathogen 2Scientists discover ancient viral invasion that shaped human genome 2Scientists discover ancient viral invasion that shaped human genome 3'Remote control' for cholesterol regulation discovered in brain 2
... Hitachi Innovative Linear Ion Trap Time of Flight Mass Analyzer for ... mode measurement range: 100 - 25,000 m/z, * Precursor ion selection ... over, * MS accuracy: 5 ppm with internal reference, * Dynamic ... ...
Four siRNAs targeting your gene of interest, providing gene silencing with 100% satisfaction guaranteed High knockdown potency , High specificity for minimal off-target effects , Flexible siR...
Mouse polyclonal antibody to BTAF1 - BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae)...
... series combines Harvard Apparatuss best pump mechanism, a ... range of configuration options. A lookup table in ... from all the major manufacturers. A bright, two ... information from across the lab. All models have ...
Biology Products: